SFCM
IMUX icon

Seven Fleet Capital Management’s Immunic IMUX Stock Holding History

Seven Fleet Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,522
Closed -$82.8K – 127
2025
Q4 		$82.8K Buy
+15,522
New +$114K 0.06% 74

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Seven Fleet Capital Management's IMUX Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Immunic (IMUX) in Q1 2026, closing a stake of 15,522 shares — an estimated $82.8K sold.

Seven Fleet Capital Management first reported a position in IMUX in Q4 2025 and held it in 1 quarter. The position peaked at $82.8K in Q4 2025. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 15,522 Immunic shares in Q1 2026, an estimated $82.8K.
  • Seven Fleet Capital Management first reported a position in Immunic in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Immunic position peaked at $82.8K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.